Revenue has consistently increased year over year, almost doubling from approximately $1.39 billion in 2023 to over $3.18 billion in 2025, showcasing strong top-line growth. The latest quarterly results demonstrate further sequential revenue growth despite some margin pressures.

Revenue growth is driven by increased patient volume and expansion of care services. While cost of revenue remains high, the company has managed to maintain gross profit margins just under 10%, indicating cost challenges but stable service pricing power.

Gross margins have declined from over 15% in early 2023 to approximately 9% recently, reflecting increasing cost pressures. Operating margins remain low near 3%, with net margins under 2%, indicative of ongoing investment and operational costs impacting profitability.

Earnings quality shows improvement with EBITDA margins doubling from roughly 4% in 2025 to over 5% most recently. However, net income remains a small fraction of revenue due to significant interest and other expenses. The recent beats against estimates suggest improving earnings visibility.

Year-over-year revenue growth was robust at approximately 48% from 2023 to 2025, with sequential quarterly growth around 1.5-2% recently. This confirms consistent top-line momentum driven by service expansion.

EPS has shown volatility but an upward trend from negative territory in 2024 to $0.3 in the latest quarter, representing a strong recovery in profitability. The latest quarter EPS beat expectations by about 3.4%.

Primary drivers include patient volume increases, expansion in care offerings, and operational efficiencies. Demand growth for specialized healthcare services and facility network expansions underpin strong revenue momentum.

Growth is largely organic, stemming from increased utilization rates and improved service delivery rather than M&A. This enhances sustainability but also implies sensitivity to market demand and competitive dynamics.

Gross margins have compressed from ~15.5% to below 10%, indicating rising costs of goods and services. However, operating margins improved to nearly 3% by Q1 2026 versus below 2% in prior years. Net margins remain thin but positive.

ROE and ROA are likely modest given the low net income margins and significant interest expenses, though improving net income signals potential for better returns if margin expansion continues.

Sustaining margins will depend on controlling costs and optimizing utilization. Competitive pricing pressure and cost inflation risks could constrain margin expansion without further efficiency improvements.